Richard E. Kuntz M.D., M.Sc.
Net Worth
Last updated:
What is Richard E. Kuntz M.D., M.Sc. net worth?
The estimated net worth of Dr. Richard E. Kuntz M.D., M.Sc. is at least $63,000,356 as of 24 Dec 2019. He owns shares worth $6,660,659 as insider, has earned $30,239,697 from insider trading and has received compensation worth at least $26,100,000 in Medtronic plc.
What is the salary of Richard E. Kuntz M.D., M.Sc.?
Dr. Richard E. Kuntz M.D., M.Sc. salary is $2,610,000 per year as Senior Vice President and Chief Medical & Scientific Officer in Medtronic plc.
How old is Richard E. Kuntz M.D., M.Sc.?
Dr. Richard E. Kuntz M.D., M.Sc. is 68 years old, born in 1957.
What stocks does Richard E. Kuntz M.D., M.Sc. currently own?
As insider, Dr. Richard E. Kuntz M.D., M.Sc. owns shares in one company:
Company | Title | Shares | Price per share | Total value |
---|---|---|---|---|
Medtronic plc (MDT) | Senior Vice President and Chief Medical & Scientific Officer | 74,032 | $89.97 | $6,660,659 |
What does Medtronic plc do?
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.
Richard E. Kuntz M.D., M.Sc. insider trading
Medtronic plc
Dr. Richard E. Kuntz M.D., M.Sc. has made 13 insider trades between 2015-2019, according to the Form 4 filled with the SEC. Most recently he sold 8,086 units of MDT stock worth $918,853 on 24 Dec 2019.
The largest trade he's ever made was exercising 81,364 units of MDT stock on 9 Jan 2018. As of 24 Dec 2019 he still owns at least 74,032 units of MDT stock.
Medtronic key executives
Medtronic plc executives and other stock owners filed with the SEC:
- Dr. Richard E. Kuntz M.D., M.Sc. (68) Senior Vice President and Chief Medical & Scientific Officer
- Mr. Bradley E. Lerman (69) Senior Vice President, Gen. Counsel & Corporation Sec.
- Mr. Geoffrey Straub Martha (55) Chairman & Chief Executive Officer
- Mr. Robert John White (62) Executive Vice President & Pres of Medical Surgical Portfolio
- Ms. Karen L. Parkhill (60) EVice President, Chief Financial Officer, IT & Enterprise Excellence